Prostate-specific antigen-based early detection of prostate cancer—validation of screening without rectal examination
- 1 January 2001
- Vol. 57 (1), 83-90
- https://doi.org/10.1016/s0090-4295(00)00863-3
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Advanced prostate cancer: Course, care, and cost implicationsThe Prostate, 1999
- Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam Region)The Prostate, 1999
- Rationale for randomised trials of prostate cancer screeningEuropean Journal Of Cancer, 1999
- Evaluation of the Digital Rectal Examination as a Screening Test for Prostate CancerJNCI Journal of the National Cancer Institute, 1998
- CHARACTERISTICS OF SCREENING DETECTED PROSTATE CANCER IN MEN 50 TO 66 YEARS OLD WITH 3 TO 4 NG./ML. PROSTATE SPECIFIC ANTIGENJournal of Urology, 1998
- Systematic 5 Region Prostate Biopsy is Superior to Sextant Method for Diagnosing Carcinoma of the ProstateJournal of Urology, 1997
- Prospective Evaluation Plan for Randomised Trials of Prostate Cancer ScreeningJournal of Medical Screening, 1996
- European randomized study of screening for prostate cancer—The Rotterdam pilot studiesInternational Journal of Cancer, 1996
- Making the most out of six systematic sextant biopsiesUrology, 1995
- Serum Prostate Specific Antigen as Pre-Screening Test for Prostate CancerJournal of Urology, 1992